Can I read Nimotuzumab in Advanced NPC: Phase III Trial on EtoBox?

Nimotuzumab in Advanced NPC: Phase III Trial by retta.adita is a document available to read on EtoBox.

What is Nimotuzumab in Advanced NPC: Phase III Trial about?

This clinical trial evaluates the efficacy of nimotuzumab combined with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC) compared to a placebo. Results showed a 5-year overall survival rate of 76.9% in the nimotuzumab group versus 64.3% in the placebo group, indicating a significant benefit. The treatment was well tolerated, with similar rates of adverse drug reactions between the two groups.

Author

retta.adita

Language

EN